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426 The Journal of Thoracic and Cardbjective: We sought to determine the histologic features of pulmonary autografts
xplanted after the Ross operation.
ethods: Histologic sections of 30 explanted autografts and 8 normal heart valves
ere compared and semiquantitatively scored by a blinded cardiovascular pathol-
gist.
esults: Pulmonary autografts (n  30) were explanted on average 6.1  0.6 years
median, 6.6 years; range, 0.1-11.7 years) after the Ross operation (n  28) or
emoved at autopsy (n  2). Twelve (43%) of the patients undergoing reoperation
ad no or negligible autograft insufficiency on early transthoracic echocardiogra-
hy, 12 (43%) had grade 1 autograft insufficiency, and 4 (14%) had grade 1-2
utograft insufficiency. Valve regurgitation with root dilatation was the most com-
on indication for reoperation after root replacement (n  26 [93%]) and regur-
itation after subcoronary implanted autografts (n  2 [7%]). Microscopy of the
utograft explants revealed normal laminar architecture and cellularity. Wall spec-
mens were characterized by reduced and fragmented elastin and increased collagen
evels (fibrosis). Medial elastin changes were associated with the presence of
ypertrophic smooth muscle cells. Fibrosis was most severe in the adventitia.
ntimal thickening was a common finding. Valve explants showed significant
hickening caused by fibrocellular tissue on the ventricular surface and marked
hickening of the free margin. An autopsy explant with normal function before death
howed similar features.
onclusions: Pulmonary autograft explants showed severe aneurysmal degeneration
f the wall, which was characterized by intimal thickening, medial elastin fragmen-
ation, and adventitial fibrosis. Valve leaflets were thickened. The presence of these
eatures in a nonfailing explant suggests these changes represent a common mode of
emodeling.
eoaortic root dilatation has become a clinical hallmark after the Ross
operation and a cause of growing concern.1-8 It can be progressive and 
often associated with regurgitation of the autograft valve. Dilatation and
egurgitation together constitute the primary cause of pulmonary autograft failure
nd the principal reason for reoperation after the Ross procedure.9 Furthermore,
issection has been reported as a possible complication of pulmonary autograft root
neurysm.10,11 The cause of dilatation, regurgitation, or both is not yet under
ut has been related to bicuspid aortic valve disease and associated developmental
rrors, preoperative diagnosis of aortic valve insufficiency or aneurysm, surgical
echnique, intraoperative trauma, and primary tissue degeneration.3,5,12-15 We hy-
othesized pulmonary autograft failure to be related to pathologic changes in the
all and the valve.
We studied microscopic sections of explanted pulmonary autografts to identify
athologic features that could play a role in clinical failure and could serve in future
tudies.
iovascular Surgery ● December 2006
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A
CDaterials and Methods
atients
ulmonary autografts of 30 patients from 4 centers were removed
t reoperation (n  28) or autopsy (n  2) between May 1992 and
anuary 2005. The involved centers performed 94% (n  416) of
able 1. Demographic and preoperative and intraoperative
ata (autograft implantation)
ariable
No. of patients
(total, n  30)
ge at autograft implantation (y)
Mean  SD 24.5  10.3
Range 6.5-42.9
Median 25.8
ex
Male 18
Female 12
rior interventions
Aortic valvotomy 3
Resection subvalvular membrane 3
Balloon dilatation 5
Aortic valve replacement 3
Sinus of Valsalva fistula closure 1
ause
AS 4
AI 10
AS/AI 13
Prosthetic dysfunction 3
unctional class
I 21
II 8
IV 1
ative aortic valve morphology
Bicuspid 15
Tricuspid 15
echnique of autograft implantation
Root replacement 28
Subcoronary 2
dditional procedures
Ascending aorta reduction 3
Annular enlargement 2
Subvalvular membrane resection 2
VSD closure 1
arly autograft regurgitation
None 2
Trace 12
Grade 1 12
Grade 1-2 4
Abbreviations and Acronyms
SD standard deviationiency; VSD, ventricular septal defect. S
The Journal of Thoracicll Ross operations in the Netherlands between 1988 and 2016
atient characteristics and details on the Ross operation or au-
ograft reoperation are given in Tables 1 and 2. Ross oper
ere performed as a root replacement (n  28) with an unsup-
orted freestanding autograft root by 10 different surgeons. Two
atients had a subcoronary implantation of the pulmonary au-
ograft. Surgical details on the mode of root implantation (on or
ithin the aortic annulus) were not consistently described in the
perative report. Echocardiographic analysis of early autograft
alve function (2 weeks after the operation) showed no or trace
nsufficiency in 12 (42.9%) of 28 and grade 1 or more insufficiency
n 16 (57.1%) of 28 patients eventually undergoing reoperations
or autograft failure. The autograft remained in place for a mean
eriod of 6.1 years after the Ross operation (median, 6.6 years;
ange, 0.1-11.7 years). The most common indication for reopera-
ion was regurgitation (grade 2) with root dilatation (maximal
chocardiographic diameter, 40 mm; n  23). Replacement of
able 2. Preoperative and intraoperative data (surgical
utograft explantation)
ariable
No. of patients
undergoing reoperation
(total, n  28)
ime interval until autograft
replacement (y)
Mean  SD 6.1  3.1
Range 0.1-11.7
Median 6.6
unctional class
I 15
II 10
III 3
oot dilatation (M-mode)
40-50 mm 7
50-60 mm 14
60 mm 4
alve regurgitation grade 2 27
urgeon’s description
Root dilatation 20
Valve abnormalities
Yes 7
No 21
perative procedure
Autograft valve replacement 8
Mechanical 7
Bioprosthesis 1
Root replacement 18
Mechanical 15
Bioprosthesis 1
Allograft 2
Valve-sparing root reconstruction 2
dditional procedures
Pulmonary allograft replacement 6
Mitral valve repair 2
Aortic reduction 2D, Standard deviation; AS, aortic valve stenosis; AI, aortic valve insuffi-
D, Standard deviation.
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1
A
CDhe entire autograft root was performed in 18 (64.3%) of 28
atients undergoing reoperation. In 8 patients only the valve was
eplaced, and in 2 patients a valve-sparing root reconstruction was
erformed. One of the 8 patients needed a subsequent root replace-
ent for aneurysmal autograft dilatation (66-mm diameter) 4 years
fter isolated autograft valve replacement. In 2 patients failure of
he autograft was associated with systemic inflammatory disease
rheumatic fever17 in 1 and Reiter syndrome in 1). At g
nspection, the explanted autograft valve looked normal to the
urgeon in 21 of 28 patients undergoing reoperation. In 7 patients
he valve showed an unrecognized quadricuspid valve (n  1),
rolapse of 1 or more cusps (n  3, one subcoronary implant), or
usp retraction (n  3, in 2 associated with inflammatory dis-
ase17). Two explants were obtained at autopsy; one patient 
uvenile rheumatoid arthritis died of heart failure 6 months after
he Ross operation because of severe regurgitation caused by
heumatic involvement of the autograft.18 Another patient with
ood autograft function died 5 years after an extended Ross
peration from pulmonary thromboembolism after stenting of a
ulmonary artery branch stenosis. There was no hospital mortality
elated to the reoperations.
istology
istologic sections used for clinical pathologic evaluation were
eevaluated. Hematoxylin and eosin, elastin van Gieson, Picro-
irius red, and Alcian blue stains were available in most autografts
r were additionally performed in case they were lacking or of
oor quality. Fibrosis in the adventitia, medial elastin fragmenta-
ion, fibrosis, mucopolysaccharide accumulation, and smooth mus-
le cell morphology and intimal hyperplasia of the wall were
emiquantitatively scored (Table 3).
Nondiseased pulmonary (n  5) and aortic (n  3) valves
iscarded for clinical use by the Dutch Heart Valve Bank in
otterdam served as control specimens. Use of these allografts for
he purpose of this study was approved by the Dutch Heart Valve
ank ethical committee. Similar stains as for autograft sections
ere used for control sections. Histologic evaluation was per-
ormed with a Leica DM 6000B light microscope (Leica Micro-
ystems, Wetzlar, Germany) by 3 observers, one of them a car-
iovascular pathologist blinded to the origin of the material.
Histologic changes were semiquantitatively scored with the use
f the criteria formulated by Schlatmann and Becker19 and de S
nd colleagues12 and supplemented by us with grading of adv-
itia fibrosis and intimal hyperplasia. Considering the histologic
ifference in medial elastin structure and valve morphology of the
ormal pulmonary artery and aorta, only pulmonary controls were
sed to score elastin fragmentation and valve parameters. Two
xplants showing rheumatic inflammation were excluded from the
nalysis.
The following criteria were used.
all
Adventitia. Fibrosis of the adventitia was examined in Picro-
irius red–stained sections at 70magnification: grade I, thickness
as comparable with that of control aortic and pulmonary sam-
les; grade II, adventitial collagen comprised less than half the
idth ( thickness) of the media; and grade III, adventitial colla-
en comprised more than half the width of the media. fi
428 The Journal of Thoracic and Cardiovascular Surgery ● DecMedia. Fibrosis was graded in Picrosirius red–stained sections
t 70 magnification: grade I, collagen areas together represented
ess than one third of total medial width; grade II, collagen areas
ogether represented between one third and two thirds of total
idth; and grade III, the estimated stained area exceeded two
hirds of the medial surface.
Elastin fragmentation was graded at 70 magnification: grade
, elastin medial architecture was comparable with that of the
ormal pulmonary wall; grade II, increased fragmentation and
verall reduction of elastin was present; and grade III, the media
howed predominant or complete lack of elastin.
Acid mucopolysaccharide accumulations graded in Alcian blue
tains at 70 magnification were defined as follows: grade I,
inute foci of mucoid material were present not more in width
han 1 lamellar unit; grade II, pools of mucoid material covering
ore than the width of a single lamellar unit but less than 3 units;
nd grade III, large pools of mucoid material more than 3 lamellar
nits in width.
Smooth muscle cell morphology was graded at 240 magni-
able 3. Histologic features of pulmonary autograft
xplants
ariable Grade
Autograft
(n)
Control
(n) P value*
all (n  22)
Adventitia fibrosis I 3 8 .001
II 11 0
III 8 0
Media
Fibrosis I 12 8 .022
II 10 0
III 0 0
Elastin fragmentation† I 5 5 .004
II 12 0
III 5 0
MPS accumulation I 10 6 .12
II 8 2
III 4 0
SMC morphology I 7 7 .009
II 10 1
III 5 0
Intimal thickness I 1 7 .001
II 14 1
III 7 0
alve (n  26)†
Fibrosa thickening  9 0 .29
 17 5
Spongiosa thickening  7 0 .56
 19 5
Ventricularis thickening  23 0 .001
 3 5
Free rim thickening  17 0 .008
 9 5
PS, Mucopolysaccharide; SMC, smooth muscle cell. *2 Test or Fisher
xact test. †P valves only were used for comparison.cation in van Gieson–stained sections as follows: grade I, small
ember 2006
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A
CDoci with change in the orientation of smooth muscle cells; grade
I, 1 or several areas of cellular reorientation together representing
etween one third and half the thickness of the media; grade III, a
arge area of cellular reorientation consisting of more than half the
edial thickness.
ntima
hickening of the intima was graded as follows: grade I, the intima
as not thickened; grade II, intima was less than one half of the
edial width; and grade III, intima was more than one half of the
edial width.
alve
alves were assessed with respect to thickening of the fibrosa,
pongiosa, and ventricularis, which was present () or absent ()
ith a width at least twice the corresponding layer of control
ulmonary valves. Cuspal free margin thickening was present ()
r absent ().
tatistical Analysis
ontinuous variables are presented as means  standard deviation
SD), and discrete variables are presented as proportions unless
tated otherwise. Histologic findings of autografts and control
pecimens were compared by using the Mann-Whitney U test
wall samples) or the Fisher exact test (valve samples). The asso-
iation between time to explantation and severity of histologic
hanges was calculated with 1-way analysis of variance and simple
inear regression. All tests were 2-sided, and a P value of less than
05 was considered significant.
esults
eneral Features
icroscopic sections of both the autograft wall and valve
ere available in 20 patients, of only the wall in 2 patients,
nd of only the valve in 6 patients (total wall sections, n 
2; total valve sections, n  26).
There was a striking difference between the wall of the
utograft and the normal aortic wall, with the autograft being
ypically thinner and containing less elastin (Figure 1). 
ordingly, autograft valves showed no similarity with aortic
alves of control specimens. Instead, the pulmonary valve
as only thickened by tissue apposition on the ventricular
urface. The severity of the histologic changes appeared
nrelated to the age of the patient or the presence or absence
f a bicuspid native aortic valve. There was a trend toward
longer mean time to explantation in those wall specimens
hat had more mucopolysaccharide accumulation (grade I vs
I vs III: 7.2 years [SD, 1.8] vs 7.2 years [SD 2.4] vs 10.1
ears [SD 2.6]; P  .09). There was a significantly longer
ean time to explantation in those valve specimens that had
entricularis thickening (7.1 years [SD 3.0] vs 2.5 years [SD
.1]; P  .03).
A histologic wall score was obtained by adding up all 6
all scores. The higher the score (defined as more wallbnormalities), the longer the mean time to explantation a
The Journal of Thoracic -
P  .10). A valve score was obtained by adding up the 3
alve scores. No association was found between valve
cores and mean time to autograft explantation.
Cystic medial necrosis, atherosclerosis, or calcification
as uniformly absent. Instead, explants showed retained
aminar architecture with apparently normal cellularity of
all and valve. Inflammatory infiltrates were only present in
he valves of a patient with a relapse of rheumatic fever and
patient with juvenile rheumatoid arthritis, demonstrating
he susceptibility of the pulmonary autograft to rheumatic
nflammation.17,18 These explants were excluded from t
nalysis.
Dissection of the autograft wall was a macroscopic find-
ng at reoperation in 1 patient and confirmed at microscopy.
egmental Wall Analysis
Adventitia. Abundant fibrosis, absent in control speci-
ens and much less in native aortic wall specimens of the
ame patient, was commonly present along the entire wall of
he pulmonary autograft (grade II in 19/22 patients, P 
001). The fibrosis was most extreme near the media, where
he individual collagen fibers typically merged into a dense
onfluent layer. Vasa vasorum were present in number and
istribution comparable with those seen in control speci-
ens (Figure 1).
Media. Collagen density was more pronounced in au-
ografts than in control pulmonary or aortic walls (grade II
n 10/22 vs 0/8, P  .022). The most prominent feature in
he media was the reduction and fragmentation of elastin.
he autograft in this respect looked distinctly different from
oth native aorta and control pulmonary artery (grade II in
7/22 compared with 0/5 pulmonary controls, P  .004).
he scarce elastin fragments were equally distributed
hroughout the media. Cysts were absent (Figure 
mooth muscle cells showed a typical morphology. In
ontrast to those in control sections, they were hypertro-
hic and appeared aligned in a radial instead of longitu-
inal direction ( grade II in 15/22, P  .009; Figure 1)
ccumulations of acid mucopolysaccharides (myxoma-
ous degeneration) of grade II or greater was present in 12
f 22 autograft specimens versus 2 of 8 control speci-
ens (P  .12).
Intima. The intima of the autograft was thickened in the
ajority of patients (grade II in 21/22 versus 1/7 control
pecimens, P  .001) also at a distance from the anasto-
osis. The neointima contained myofibroblasts and stained
ositive for collagen.
Valve. The valve showed retained laminar architecture
nd interstitial cellularity but was thickened by tissue appo-
ition on the ventricular surface. The extra layer, irregular in
hickness and extension, was present in the majority of
pecimens (23/26 versus 0/5 control specimens, P  .001)
nd sometimes caused a significant thickness increase. Like
and Cardiovascular Surgery ● Volume 132, Number 6 1429
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A
CDntimal hyperplasia, it contained myofibroblasts and proteo-
lycans but also stained for elastin and collagen (Figur
Changes in the 2 subcoronary explants were more severe,
ith grossly disturbed laminar architecture and considerable
clerotic thickening. Fibrosa and spongiosa thickening was
ess frequently found and did not differ from that seen in
ontrol specimens (9/26 and 7/26, respectively; P .29 and
 .56). Most cusps had club-like thickening of the free
argin of the valve (17/26 versus 0/8 control specimens,
Figure 1. Normal aortic and pulmonary walls and
pulmonary autograft explanted 11 years and 9 months a
logic features. (Resorcin-Fuchsin, 60 and 240 magn
tissue on the ventricular surface (middle left panel). T
fibrosis. Elastin in the media is significantly reduced an
cells. The intima is thickened (middle right and lower .008) containing fibroblasts and collagen. C
430 The Journal of Thoracic and Cardiovascular Surgery ● Dec.
iscussion
he present study demonstrates that most explanted pulmo-
ary autografts show histologic changes that are not found
n normal valves. The autograft valve showed increased
hickness as the most remarkable feature but did not look
ike a true aortic valve. Instead, the delicate pulmonary
alve architecture was maintained, which was thickened by
n additional layer of fibrocellular tissue on the ventricular
urface (Figure 1). A similar phenomenon was reported
s (upper panels) compared with micrographs of a
he Ross operation showing representative histopatho-
ion.) The valve is moderately thickened by elastin-rich
ventitia contains vasa vasorum and shows extensive
gmented and replaced by hypertrophic smooth muscle
els).valve
fter t
ificat
he ad
d fra
panhambers and associates20 in an autograft removed after 26
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A
CDears, who described it as “fibrosis and thickening of the
dventitia” (Figure 7 of their publication); by Rabkin-
ikawa and coworkers,21 who described the intimal thic-
ning on the ventricular aspect as pannus; and by Goffin and
olleagues,22 attributing “enlargement of the ventriculari
o the effect of jet lesion. These are various interpretations
f a similar observation, which we think is an important
ffect of adaptive remodeling of the autograft valve. It is
robably the result of attempted restoration of normal stress
train relations after the increase of tensile and shear stress
n the systemic circulation. It might enhance mechanical
trength but also influence valve function by restricting
adial extensibility. Therefore it might play a role in the
ause of pulmonary autograft regurgitation.
Changes in the wall of the autograft were more severe.
irst of all, in accordance with valvular changes, the wall
howed no resemblance with either normal pulmonary or
ormal aortic walls. This important observation was made
efore in animals.15 It is important because it underlines t
he aortic and pulmonary valves are distinctly different
tructures and that the fact that the aortic and pulmonary
oots arise from a common embryologic trunk does not
ean that the pulmonary valve can become a morphologic
ortic valve. Instead, the pulmonary wall showed increased
ollagen content and loss of elastin. The resulting neoaortic
all had lost the typical characteristics of a large elastic
rtery, missing a robust elastin-rich media and a delicate
dventitia, and showed severe degenerative changes instead.
oss and fragmentation of medial elastin are important
istopathologic features in both pulmonary and abdominal,
s well as in thoracic, aortic aneurysms.23-25 Autograft
neurysms might share a similar clinical behavior with a
endency toward progressive dilatation, compression, and
upture or dissection. This has indeed been observed in
ulmonary autograft roots.10,11
The observed increase in collagen and loss of elastin
ight have functional implications and might theoretically
imit the distensibility of the root. This has been confirmed
y means of magnetic resonance imaging of pulmonary
utograft roots in patients.26 Increased root stiffness in tu
nfluences valve function and valve stress and might there-
ore also contribute to valve failure by accelerating degen-
rative changes.27
Smooth muscle cells, the principal collagen- and elastin-
roducing cells of the vascular wall, showed a typical mor-
hology in the autograft wall. They were hypertrophic and
ppeared realigned, indicating a rearrangement of the cy-
oskeleton as a sign of cellular activity. Whereas a quiescent
ellular state would be expected after completion of au-
ograft adaptation, 12 years after the Ross operation, cellular
ypertrophy was still visible (Figure 1). Similar smo
uscle cell hypertrophy was observed in aortic aneurysmal
all– derived smooth muscle cells,28 confirming the aneu- l
The Journal of Thoracicysmal nature of the autograft roots. Smooth muscle cells of
utografts possibly remain involved in matrix production as
result of failure to reestablish wall stress homeostasis. A
ontinuous demand of matrix-producing cells might accel-
rate senescence and eventually cause the production of
oor-quality structural proteins unable to maintain adequate
all integrity. This could be an explanation for the tendency
f autografts to become aneurysmal. A similar pathobio-
ogic mechanism might play a role in valvular interstitial
ells. Such an assumption is supported by Rabkin-Aikawa
nd associates,21,29 who observed that levels of the matrix-
emodeling enzyme matrix metalloproteinase 13 of pul-
onary autograft valves did not return to the baseline
evels of normal control valves up to 6 years after au-
ograft implantation.
Interestingly, both aneurysmal and nonaneurysmal au-
ograft wall sections showed similar pathologic changes in
ur study. Rabkin-Aikawa and associates21 also found com-
arable changes in autografts that were either removed at
urgical intervention or at autopsy or transplantation, which
lso suggests that a common mode of adaptive remodeling
ight play a role that can eventually cause degeneration.
On the basis of our findings, we can speculate on the
ause of aneurysmal autograft wall degeneration. Failing of
he remodeling process might be related to the fact that
ulmonary autograft cells lack the genetic characteristics to
dequately address the functional needs required in the left
entricular outflow tract. Adaptation of the pulmonary root
o these left ventricular outflow tract conditions might in
act be beyond biologic allowance and perhaps be as de-
anding as adaptation of the right ventricle to function as a
eft ventricle. It might work for a long time but eventually
ails relatively early in many. In this regard it would also be
ery interesting to assess the function of the pulmonary
alve in the systemic circulation long term after the arterial
witch operation, the Damus-Kaye-Stansel operation, or the
orwood operation to compare pulmonary autograft pathol-
gy with that of other pulmonary valves that were made to
unction in the systemic circulation.
We conclude that the pulmonary autografts we explanted
ecause of clinical failure and at autopsy showed aneurys-
al degeneration of the wall and significant microscopic
hickening of the valve.
Future studies should validate our observations and sup-
ositions. Transcriptional biomarkers involved in aneurys-
al autograft dilatation and valve dysfunction could be
etermined by means of microarray technology. Matrix
nalysis is required to qualify and quantify our light micro-
copic observations.
Tissue harvesting was performed by 10 different sur-
eons and processing and staining by 4 different pathologic
ervices. The resulting sample heterogeneity is an important
imitation to this study. We used a gross type of semiquan-
and Cardiovascular Surgery ● Volume 132, Number 6 1431
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CDitative grading system, providing only a semiquantitative
mpression of major pathologic features. Control specimens
ere not from age-matched subjects, which could have
ntroduced incorrections with respect to the observed
iscrepancies.
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